Skip to main content
Aequus Pharmaceuticals Inc. (TSXV:AQS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Apr 25, 2025, 9:30 AM EST

Aequus Pharmaceuticals Revenue

Aequus Pharmaceuticals had revenue of 251.75K CAD in the quarter ending September 30, 2025, with 69.74% growth. This brings the company's revenue in the last twelve months to 918.47K, up 122.30% year-over-year. In the year 2024, Aequus Pharmaceuticals had annual revenue of 584.24K with 129.21% growth.

Revenue (ttm)
918.47K
Revenue Growth
+122.30%
P/S Ratio
0.72
Revenue / Employee
n/a
Employees
12
Market Cap
663.17K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024584.24K329.34K129.21%
Dec 31, 2023254.90K-1.12M-81.53%
Dec 31, 20221.38M-1.33M-49.17%
Dec 31, 20212.71M122.09K4.71%
Dec 31, 20202.59M960.09K58.81%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Captor Capital -1.12M
Optimind Pharma 131.48K
Global Health Clinics 30.63K
Vibe Growth 22.19M
Vencanna Ventures 3.60M
Adastra Holdings 16.86M
Revenue Rankings

Aequus Pharmaceuticals News

More News